; (3) an estimate of the number of individuals impacted by the laws described in paragraph (1), including the number of individuals who have received legal protections or immunities under such laws; (4) analyze the impact of the laws described in paragraph (1), including— (A) an assessment of changes in overdose-related fatalities, emergency department visits, and the use of naloxone or other overdose reversal interventions; and (B) data on the number of calls received for overdoses before and after the implementation of such laws; (5) evaluate the effectiveness of grant funding provided to States and localities for the purpose of spreading awareness about the laws described in paragraph (1); (6) assess the reach and impact of educational campaigns, community outreach initiatives, and training programs aimed at informing the public, healthcare providers, law enforcement personnel, and other relevant stakeholders about the protections and benefits provided by the laws described in paragraph (1); (7) identify any barriers or challenges encountered during the implementation of the laws described in paragraph (1) and associated awareness campaigns, including— (A) examining the legal, logistical, resource-related, or cultural factors that may impede successful adoption and utilization of the laws; and (B) exploring any challenges faced by individuals seeking help or reporting overdoses due to potential legal repercussions; (8) highlight any best practices identified in States and localities that have effectively implemented the laws described in paragraph (1) and conducted successful awareness campaigns; (9) provide recommendations for improving the implementation and impact of the laws described in paragraph (1) and optimizing the use of grant funding for education and outreach efforts